Looks like you and others are starting to finally get it. I always had faith that you would since you do some good analysis.
But you can see now what I have been talking about-
-hostile takeover.
-Simes the crook sold us out
-30+ million dollar screwup bankrupting the company for all intents and purposes
-getting in bed with TANG only to sodomized by them with open shorting on the market (forced to sell at BELOW market value on top of that!!!)
-ANI merging for our 40m CASH and free listing.
-CVR vouchers probably no more valuable than a roll of common toilet paper. This is b/c they will sell the Libigel fiasco to to Abbie most likely for PENNIES. You and I will take the hit on the 30+ million dollar discount it will be sold for.
-ANI keeps the GVAX portfolio that has no current value for us but costs us nothing as well. If that actually pans out- ANI wins. Or maybe they sell that too! Guess how much say you will have in that decision- ZERO!!!
Simes is being kicked out for his incompetence and I suggest a class action against him demanding full discovery on contingency with a law firm. He will not be protected by the corporate veil laws once he is dumped on the street. THE BOD and TANG as well!
I think the weakness here was that BioSante was bullied into a lot of this due to Sime's stupidity. But those who carried out the attacks may have broken enough laws to generate a case. It all happened pretty fast since last December.
Naked short attacks (which have actually been successfully prosecuted).
Coercion into issuance of shares to TANG at below market prices.
A review of the BOD decision to do a reverse split.
Review of the fiduciary responsibility of the BOD and executives of BPAX in going into this ANI "deal".
Possible witholding of materially relevant information.
Issuance of potentially false statements as to the viability of Libigel.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.